Alnylam Pharmaceuticals OverviewAlnylam Pharmaceuticals Net Income
Profitability analysis for ALNY.
Quarterly Net Income
$205.99M
↑ 458.38% YoY
As of Mar 2026
Annual Net Income (TTM)
$577.22M
↑ 314.02% YoY
Trailing 12 months ending Mar 2026
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...